51
Michael J Crooks: Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators. Cohen Pontani Lieberman Pavane, December 8, 1992: US05169846 (12 worldwide citation)

A non-aqueous micellar solution, for use in animal health, of one or more non water-soluble Anthelmintics and or insect growth regulators in a polyethoxylated oil or fat surfactant and one or more co-solvents chosen from a group comprising dimethyl sulphoxide (DMSO), N-methyl pyrollidone (NMP), tetr ...


52
Bruno Suri, Catherine Georges, John Edmondson Peel: Method for the prevention and treatment of mastitis. Novartis Animal Health U S, Michael P Morris, William A Teoli Jr, February 13, 2001: US06187800 (12 worldwide citation)

A method for treating or preventing mastitis in mammals is disclosed. The method contemplates the intramammary injection or dipping the teat with micrococcin antibiotics, preferably micrococcin P1 or P2, which do not interfere with the production of cheese and yoghurt using milk from treated animals ...


53

54
Burt L Kuhn: Animal medication dispenser. AKDOV Animal Health Care Products, Cahill Sutton & Thomas, August 9, 1977: US04040422 (11 worldwide citation)

A device for introducing food or medicine into an animal's mouth, the device being in the form of a bit having a longitudinally extending cavity, a connector for attaching a supply of medicine to the bit, the connector providing a passage for introducing the medicine to the cavity, and a plunger for ...


55
Scott Hecker, Sunil V Pansare, Tomasz W Glinka: Florfenicol prodrug having improved water solubility. Schering Plough Animal Health Corporation, December 26, 2006: US07153842 (11 worldwide citation)

The present invention discloses phosphate esters of florfenicol (prodrugs) and florfenicol analogs having superior water solubility that are hydrolyzed to florfenicol or the respective florfenicol analog in vivo, upon administration to an animal.


56
Gill Michael A: Canine coronavirus vaccine from feline enteric coronavirus.. Solvay Animal Health, August 31, 1994: EP0612532-A2 (11 worldwide citation)

This invention provides a vaccine which contains, per dose, an effective immunizing amount of a modified feline enteric coronavirus and a suitable carrier. The vaccine of this invention may also contain an adjuvant, an effective immunizing amount of a second modified virus and a an effective immuniz ...


57
Mcmillan Kirk: Metabolic kinase modulators and methods of use as pesticides. Exelixis, Mcmillan Kirk, GREENFIELD Michael, September 22, 2005: WO/2005/087742 (11 worldwide citation)

This invention relates to compounds that can be used as pesticides, in particular their use as agents in the control of pests for crop protection, human and animal health, and home and garden applications. More specifically, this invention relates to the use of compounds that modulate metabolic kina ...


58
Malik Merza: Hybridoma producing antibodies to lawsonia intracellularis. Boehringer Ingelheim Vetmedica, Michael P Morris, Mary Ellen M Devlin, Joyce L Morrison, September 21, 2010: US07799562 (10 worldwide citation)

The present invention relates to the field of animal health and in particular to Lawsonia intracellularis. In particular, the invention relates to a method of diagnosing Lawsonia intracellularis infection and a diagnostic test kit using Lawsonia intracellularis-specific antibodies. The invention als ...


59
Dale E Shuster, Scott Hecker, Tomasz W Glinka, Rajeshwar Singh, Zhuoyi Su: Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof. Schering Plough Animal Health Corporation, April 22, 2008: US07361689 (10 worldwide citation)

Novel florfenicol compounds having the chemical structure: or a pharmaceutically-acceptable salt thereof or a solvate thereof, or prodrug thereof, wherein R1 is CHCl2, CHClF, CHF2, CHBrCl, CH3, CH2N3, CH2CN, CH(R2)NH2 or CH X1X2; where R2 is H, CH3 or CH2OH, and X1 and X2 are independently selected ...


60
Chladek Danny W, Gorcyca David E, Harris Louis L: Agent viral associe a la maladie mysterieuse du porc, Viral agent associated with mystery swine disease. Boehringer Ingelheim Animal Health, FETHERSTONHAUGH & CO, June 27, 2000: CA2076744 (10 worldwide citation)

A viral agent that will mimic "mystery swine" diseasehas been isolated and described, together with a method ofgrowing the viral agent in vitro, and a method of attenuatingthe virus for vaccine preparation.